CN103800843A - Traditional Chinese medicine composition for treating chronic pelvic inflammation - Google Patents
Traditional Chinese medicine composition for treating chronic pelvic inflammation Download PDFInfo
- Publication number
- CN103800843A CN103800843A CN201410099830.4A CN201410099830A CN103800843A CN 103800843 A CN103800843 A CN 103800843A CN 201410099830 A CN201410099830 A CN 201410099830A CN 103800843 A CN103800843 A CN 103800843A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention relates to a traditional Chinese medicine composition for treating chronic pelvic inflammation. The traditional Chinese medicine composition is prepared from the following raw pharmaceutical materials in parts by weight: 27-33 parts of sargentgloryvine, 27-33 parts of whiteflower patrinia herb, 27-33 parts of dandelion, 27-33 parts of selfheal spike, 17-23 parts of coix seed, 17-23 parts of rhizoma smilacis glabrae, 15 parts of angelica root, 15 parts of akebia stem, 15 parts of cassia twig, 15 parts of phellodendron bark, 15 parts of atractylodes rhizome, 15 parts of astragalus root, 15 parts of codonopsis pilosula, 15 parts of white peony root, 15 parts of corydalis tuber, 15 parts of costus root, 15 parts of triquetrous, 15 parts of zedoary, 15 parts of nutagrass flatsedge rhizome and 3-7 parts of licorice root. The traditional Chinese medicine composition has the advantages of stable treatment effect and no side effects.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease.
Background technology
Pelvic inflammatory disease refers to the inflammation that female pelvic cavity genitals and connective tissue around thereof, pelvic peritoneum occur, and is divided into acute and chronic two kinds.Clinical research shows, hypogastric region constant pain and leucorrhoea grow in quantity are its cardinal symptom.At pelvic inflammatory disease acute attack stage often with symptoms such as generating heat, have a headache, be afraid of cold, and chronic pelvic inflammatory disease between period of disease often with the soreness of waist, abdominal pain in menstruation, through the symptom such as measuring too much, if treatment not in time can be shone into secondary infertility because of atresia of uterine tube.In recent years, its sickness rate is more and more higher, has become common gynecological disease, has had a strong impact on numerous women's physical and mental health, brings inconvenience to work, life.
At present, the medicine for the treatment of chronic pelvic inflammatory disease is more, but has the deficiencies such as curative effect is unstable, side effect is large.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides a kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease, the present invention has advantages of stable curative effect, has no side effect.
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, made by the crude drug of following weight portion: Caulis Sargentodoxae 27-33 part, Herba Patriniae 27-33 part, Herba Taraxaci 27-33 part, Spica Prunellae 27-33 part, Semen Coicis 17-23 part, Rhizoma Smilacis Glabrae 17-23 part, Radix Angelicae Sinensis 9-15 part, Caulis Akebiae 9-15 part, Ramulus Cinnamomi 9-15 part, Cortex Phellodendri 9-15 part, Rhizoma Atractylodis 9-15 part, Radix Astragali 9-15 part, Radix Codonopsis 9-15 part, Radix Paeoniae Alba 9-15 part, Rhizoma Corydalis 9-15 part, Radix Aucklandiae 9-15 part, Rhizoma Sparganii 9-15 part, Rhizoma Curcumae 9-15 part, Rhizoma Cyperi 9-15 part, Radix Glycyrrhizae 3-7 part.
The Chinese medicine composition of described treatment chronic pelvic inflammatory disease, it is preferably made up of the crude drug of following weight portion: 30 parts of Caulis Sargentodoxae, 30 parts of Herba Patriniae, 30 parts of Herba Taraxacis, 30 parts of Spica Prunellaes, 20 parts of Semen Coiciss, 20 parts of Rhizoma Smilacis Glabraes, 12 parts of Radix Angelicae Sinensis, 12 parts of Caulis Akebiaes, 12 parts of Ramulus Cinnamomi, 12 parts of Cortex Phellodendris, 12 parts of Rhizoma Atractylodis, Radix Astragali part, 12 parts of Radix Codonopsis, 12 parts of the Radix Paeoniae Albas, 12 parts of Rhizoma Corydalis, 12 parts of the Radix Aucklandiae, 12 parts of Rhizoma Sparganii, 12 parts of Rhizoma Curcumae, 12 parts of Rhizoma Cyperis, 5 parts, Radix Glycyrrhizae.
The preparation method of the Chinese medicine composition of described treatment chronic pelvic inflammatory disease is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
The application of the Chinese medicine composition of described treatment chronic pelvic inflammatory disease in preparation treatment chronic pelvic inflammatory disease medicine.
The beneficial effect that the present invention compared with prior art had is: the present invention is under Traditional Chinese medical theory and clinical experience guidance, choose each crude drug and proportioning thereof, there is the function of dispelling cold by warming the meridian, blood nourishing acupuncture-stimulating, blood circulation promoting and blood stasis dispelling, realize the object for the treatment of chronic pelvic inflammatory disease.
Below in conjunction with clinical experiment, beneficial effect of the present invention is described:
(1) clinical data: the present invention treats undergoing chronic pelvic inflammation 85 examples altogether, the age is 20-42 year.
(2) Therapeutic Method: the oral drugs that Chinese medicine composition of the present invention is made can be decoction, tablet, pill and capsule etc., take decoction as example, 1 pair of every day, point takes for 2 times, early, respectively take 1 evening, within 10 days, is 1 course for the treatment of.
(3) the standard of curative effect evaluation:
Cure: clinical symptoms disappears completely;
Take a turn for the better: clinical symptoms is obviously improved;
Do not heal: clinical primary symptom shape does not improve.
(4) therapeutic outcome: the present invention treats undergoing chronic pelvic inflammation 85 examples altogether, through 1-3 course of therapy, cures 76 examples, accounts for 89.4%, and 6 examples that take a turn for the better, account for 7.1%, and 3 examples that do not heal, account for 3.5%, and effective percentage is 96.5%, has no any side effect; Cure in 76 examples, cure 19 examples 1 course for the treatment of, cure 21 examples 2 courses for the treatment of, cure 36 examples 3 courses for the treatment of, follows up a case by regular visits to half by 1 year after healing, is showed no recurrence; Result shows, the present invention has advantages of stable curative effect, has no side effect.
(5) model case:
1, military so-and-so, 40 years old, patient's sterillization 2 years, leukorrhagia dysmenorrhea 1 year, over nearly 1 year, HUANGBAI(sic) band therapeutic method to keep the adverse QI flowing downwards fishy smell is turbid, waist abdomen pendant pain, before menses mistake, (about 25 days) dark matter of color is dense, 7 Japanese sides are clean.Through presensation perineum and abdominal part distending pain, shape is as given birth to a child, and suffering can't bear, and must can alleviate with tablet for alleviating pain.Its tongue is at prime, and tongue is slightly yellow, thready and stringy pulse and counting.Gynecologial examination: pudendum is presentation, vaginal congest, rotten in cervix uteri lower lip, adnexa left side thickens tenderness, palace body normal in size, leucorrhea microscopy: erythrocyte (+), dense ball (+), card belongs to the heresy stagnant dai channel of a specified duration of turbid damp, and stagnation of blood stasis and heat becomes leukorrhagia; Take after 2 courses for the treatment of of Chinese medicine preparation of the present invention, leukorrhagia is gradually few, and it is light that color turns, and waist abdomen pendant pain obviously alleviates, and continues to take 1 course for the treatment of of Chinese medicine preparation of the present invention, and within 28 days, extremely color is at prime in this time menstruation, and four days clean, and stomachache and all diseases disappear.
2, grandson, 35 years old, lower abdomen pain pendant rose more than 2 years, before 2 years, gets ring, and the time is longer, postoperative sense hypogastralgia, pudendum pendant rises, and lumbosacral region is ached, the belt transect of bleeding.Gynecologial examination has inflammatory mass, and B ultrasonic shows endometritis, through examining: irregular menstrual period, the few color of amount is dark, pale tongue with white fur, deep-slow pulse; Take 1 course for the treatment of of Chinese medicine preparation of the present invention, hypogastric region and perineal position pain pendant rise and alleviate, and the few color of leukorrhagia amount is white, continue to take 1 course for the treatment of of Chinese medicine preparation of the present invention, the disappearance of rising of hypogastric region and perineum pain pendant, menstrual period are normal, gynecologial examination, inflammatory mass disappears, B ultrasonic check uterus no abnormality seen.
The specific embodiment
Embodiment 1:
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, made by the crude drug of following weight portion: 27 parts of Caulis Sargentodoxae, 27 parts of Herba Patriniae, 27 parts of Herba Taraxacis, 27 parts of Spica Prunellaes, 17 parts of Semen Coiciss, 17 parts of Rhizoma Smilacis Glabraes, 9 parts of Radix Angelicae Sinensis, 9 parts of Caulis Akebiaes, 9 parts of Ramulus Cinnamomi, 9 parts of Cortex Phellodendris, 9 parts of Rhizoma Atractylodis, 9 parts of the Radixs Astragali, 9 parts of Radix Codonopsis, 9 parts of the Radix Paeoniae Albas, 9 parts of Rhizoma Corydalis, 9 parts of the Radix Aucklandiae, 9 parts of Rhizoma Sparganii, 9 parts of Rhizoma Curcumae, 9 parts of Rhizoma Cyperis, 3 parts, Radix Glycyrrhizae.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 2:
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, made by the crude drug of following weight portion: 30 parts of Caulis Sargentodoxae, 30 parts of Herba Patriniae, 30 parts of Herba Taraxacis, 30 parts of Spica Prunellaes, 20 parts of Semen Coiciss, 20 parts of Rhizoma Smilacis Glabraes, 12 parts of Radix Angelicae Sinensis, 12 parts of Caulis Akebiaes, 12 parts of Ramulus Cinnamomi, 12 parts of Cortex Phellodendris, 12 parts of Rhizoma Atractylodis, Radix Astragali part, 12 parts of Radix Codonopsis, 12 parts of the Radix Paeoniae Albas, 12 parts of Rhizoma Corydalis, 12 parts of the Radix Aucklandiae, 12 parts of Rhizoma Sparganii, 12 parts of Rhizoma Curcumae, 12 parts of Rhizoma Cyperis, 5 parts, Radix Glycyrrhizae.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 3:
Treat a Chinese medicine composition for chronic pelvic inflammatory disease, made by the crude drug of following weight portion: 33 parts of Caulis Sargentodoxae, 33 parts of Herba Patriniae, 33 parts of Herba Taraxacis, 33 parts of Spica Prunellaes, 23 parts of Semen Coiciss, 23 parts of Rhizoma Smilacis Glabraes, 15 parts of Radix Angelicae Sinensis, 15 parts of Caulis Akebiaes, 15 parts of Ramulus Cinnamomi, 15 parts of Cortex Phellodendris, 15 parts of Rhizoma Atractylodis, 15 parts of the Radixs Astragali, 15 parts of Radix Codonopsis, 15 parts of the Radix Paeoniae Albas, 15 parts of Rhizoma Corydalis, 15 parts of the Radix Aucklandiae, 15 parts of Rhizoma Sparganii, 15 parts of Rhizoma Curcumae, 15 parts of Rhizoma Cyperis, 7 parts, Radix Glycyrrhizae.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Claims (4)
1. a Chinese medicine composition for the treatment of chronic pelvic inflammatory disease, is characterized in that: the crude drug by following weight portion is made: Caulis Sargentodoxae 27-33 part, Herba Patriniae 27-33 part, Herba Taraxaci 27-33 part, Spica Prunellae 27-33 part, Semen Coicis 17-23 part, Rhizoma Smilacis Glabrae 17-23 part, Radix Angelicae Sinensis 9-15 part, Caulis Akebiae 9-15 part, Ramulus Cinnamomi 9-15 part, Cortex Phellodendri 9-15 part, Rhizoma Atractylodis 9-15 part, Radix Astragali 9-15 part, Radix Codonopsis 9-15 part, Radix Paeoniae Alba 9-15 part, Rhizoma Corydalis 9-15 part, Radix Aucklandiae 9-15 part, Rhizoma Sparganii 9-15 part, Rhizoma Curcumae 9-15 part, Rhizoma Cyperi 9-15 part, Radix Glycyrrhizae 3-7 part.
2. the Chinese medicine composition for the treatment of chronic pelvic inflammatory disease according to claim 1, is characterized in that: the crude drug by following weight portion is made: 30 parts of Caulis Sargentodoxae, 30 parts of Herba Patriniae, 30 parts of Herba Taraxacis, 30 parts of Spica Prunellaes, 20 parts of Semen Coiciss, 20 parts of Rhizoma Smilacis Glabraes, 12 parts of Radix Angelicae Sinensis, 12 parts of Caulis Akebiaes, 12 parts of Ramulus Cinnamomi, 12 parts of Cortex Phellodendris, 12 parts of Rhizoma Atractylodis, Radix Astragali part, 12 parts of Radix Codonopsis, 12 parts of the Radix Paeoniae Albas, 12 parts of Rhizoma Corydalis, 12 parts of the Radix Aucklandiae, 12 parts of Rhizoma Sparganii, 12 parts of Rhizoma Curcumae, 12 parts of Rhizoma Cyperis, 5 parts, Radix Glycyrrhizae.
3. the preparation method of the Chinese medicine composition for the treatment of chronic pelvic inflammatory disease according to claim 1 and 2, is characterized in that: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
4. the application of the Chinese medicine composition for the treatment of chronic pelvic inflammatory disease according to claim 1 and 2 in preparation treatment chronic pelvic inflammatory disease medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410099830.4A CN103800843B (en) | 2014-03-18 | 2014-03-18 | A kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410099830.4A CN103800843B (en) | 2014-03-18 | 2014-03-18 | A kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103800843A true CN103800843A (en) | 2014-05-21 |
| CN103800843B CN103800843B (en) | 2016-05-11 |
Family
ID=50698538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410099830.4A Expired - Fee Related CN103800843B (en) | 2014-03-18 | 2014-03-18 | A kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103800843B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189651A (en) * | 2014-09-29 | 2014-12-10 | 洛阳御平国生物科技有限公司 | Formula for treating pelvic inflammatory disease |
| CN104436029A (en) * | 2014-11-13 | 2015-03-25 | 廖福存 | Drug for treating pelvic inflammatory disease |
| CN104587402A (en) * | 2015-01-29 | 2015-05-06 | 巫军 | Traditional Chinese medicine preparation for treating chronic pelvic inflammatory disease and preparation method of traditional Chinese medicine preparation |
| CN104940805A (en) * | 2015-05-29 | 2015-09-30 | 华洪萍 | Traditional Chinese medicine for treating pelvic inflammation |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103191375A (en) * | 2013-04-19 | 2013-07-10 | 张金梅 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory diseases |
-
2014
- 2014-03-18 CN CN201410099830.4A patent/CN103800843B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103191375A (en) * | 2013-04-19 | 2013-07-10 | 张金梅 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory diseases |
Non-Patent Citations (3)
| Title |
|---|
| 李晓燕，等: "《门诊处方全书》", 31 July 2012, article "《中医处方》", pages: 315-317 * |
| 韩惠兰，等: "慢性盆腔炎的中医治疗", 《中国全科医学》, vol. 4, no. 8, 31 August 2001 (2001-08-31), pages 603 - 606 * |
| 黄应培，等: "中医药治疗慢性盆腔炎的研究进展", 《湖南中医杂志》, vol. 28, no. 1, 31 January 2012 (2012-01-31), pages 122 - 124 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189651A (en) * | 2014-09-29 | 2014-12-10 | 洛阳御平国生物科技有限公司 | Formula for treating pelvic inflammatory disease |
| CN104436029A (en) * | 2014-11-13 | 2015-03-25 | 廖福存 | Drug for treating pelvic inflammatory disease |
| CN104587402A (en) * | 2015-01-29 | 2015-05-06 | 巫军 | Traditional Chinese medicine preparation for treating chronic pelvic inflammatory disease and preparation method of traditional Chinese medicine preparation |
| CN104587402B (en) * | 2015-01-29 | 2016-01-20 | 宁波保税区欣诺生物技术有限公司 | A kind of Chinese medicine preparation for the treatment of chronic pelvic inflammatory disease and preparation method thereof |
| CN104940805A (en) * | 2015-05-29 | 2015-09-30 | 华洪萍 | Traditional Chinese medicine for treating pelvic inflammation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103800843B (en) | 2016-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhou et al. | Treating gynaecological disorders with traditional Chinese medicine: a review | |
| CN102370725B (en) | A kind of compound Chinese medicinal preparation treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN103386086B (en) | Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof | |
| CN102872418A (en) | Medicine for treating pelvic inflammation | |
| CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN101653590B (en) | Medicine for treating habitual abortion and preparation method thereof | |
| CN103393913B (en) | Chinese medicinal composition for treating uterine prolapse | |
| CN102284050B (en) | Chinese medicine composition for treating infertility caused by cold uterus | |
| CN103800843A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN103990099A (en) | Traditional Chinese medicine composition for treating dysmenorrhea | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN104435519A (en) | Pharmaceutical composition for treating primary dysmenorrhea | |
| CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
| CN103893671A (en) | Pharmaceutical composition for treating hysteromyoma | |
| CN105194584A (en) | Medicine for treating dysmenorrhea | |
| CN104873706A (en) | Traditional Chinese medicine composition for treating uterine cold infertility | |
| CN103989803A (en) | Traditional Chinese medicine for treating infertility | |
| CN103705846A (en) | Traditional Chinese medicine preparation for treating ovarian cyst | |
| CN103751480A (en) | Traditional Chinese medicine for treating habitual abortion | |
| CN103550668B (en) | A kind of Chinese medicine for the treatment of gynecological's habitual abortion disease | |
| CN103800746A (en) | Traditional Chinese medicine composition for treating acute pelvic inflammation | |
| CN102475866A (en) | Medicine for preventing abortion and preparation method thereof | |
| CN102743686B (en) | The scorching clearing capsule of a kind of basin | |
| CN103800664A (en) | Traditional Chinese medicine composition for treating menopausal syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Shengmiao Inventor after: Huang Xin Inventor after: Ji Tao Inventor after: Chen Long Inventor before: Huang Shujuan |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160411 Address after: 266011 Jiaozhou Road, Shandong, China, No. 1, No. Applicant after: Qingdao Municipal Hospital Address before: B ultrasonic room, Huaishang District Mo He Kou Zhen 233000 Anhui city of Bengbu province to build a hospital Applicant before: Huang Shujuan |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160511 Termination date: 20170318 |